📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The utility of a differentiated preclinical liver model, HepaRG cells, in investigating delayed toxicity via inhibition of mitochondrial-replication induced by fialuridine. (2020)

First Author: Jolly CE

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.taap.2020.115163

PubMed Identifier: 32730777

Publication URI: http://europepmc.org/abstract/MED/32730777

Type: Journal Article/Review

Volume: 403

Parent Publication: Toxicology and applied pharmacology

ISSN: 0041-008X